Pallas Capital Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $754K | Sell |
31,106
-19,055
| -38% | -$462K | 0.03% | 391 |
|
|
2025
Q1 | $1.27M | Sell |
50,161
-100,901
| -67% | -$2.56M | 0.05% | 259 |
|
|
2024
Q4 | $4.01M | Buy |
151,062
+125,351
| +488% | +$3.33M | 0.17% | 107 |
|
|
2024
Q3 | $736K | Buy |
25,711
+9,102
| +55% | +$261K | 0.03% | 281 |
|
|
2024
Q2 | $493K | Buy |
16,609
+5,104
| +44% | +$152K | 0.02% | 309 |
|
|
2024
Q1 | $319K | Buy |
+11,505
| New | +$319K | 0.01% | 352 |
|
|
2022
Q1 | – | Sell |
-9,290
| Closed | -$490K | – | 279 |
|
|
2021
Q4 | $490K | Sell |
9,290
-2,205
| -19% | -$116K | 0.06% | 195 |
|
|
2021
Q3 | $515K | Sell |
11,495
-3,823
| -25% | -$171K | 0.06% | 224 |
|
|
2021
Q2 | $692K | Buy |
15,318
+7,995
| +109% | +$361K | 0.1% | 156 |
|
|
2021
Q1 | $292K | Buy |
+7,323
| New | +$292K | 0.07% | 157 |
|